Medicare Enrolled

Dr. Mark Klafter, D.O.

Neurology · Orlando, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
3849 OAKWATER CIR, Orlando, FL 32806
4072401762
In practice since 2005 (20 years)
NPI: 1730161639 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Klafter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Klafter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Klafter

Dr. Mark Klafter is a neurology in Orlando, FL, with 20 years in practice. Based on federal Medicare data, Dr. Klafter performed 1,677 Medicare services across 1,155 unique beneficiaries.

Between the years covered by Open Payments, Dr. Klafter received a total of $246,073 from 87 pharmaceutical and/or device companies across 1955 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Klafter is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 23% volume in FL$ $246,073 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,677
Medicare services
Top 23% in FL for neurology
1,155
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~84 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)377$90$225
Office visit, established patient, complex (40-54 min)312$136$302
Needle measurement of electrical activity in arm or leg muscles, complete study225$75$175
Telephone medical discussion with physician, 11-20 minutes145$66$100
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle81$15$200
New patient office visit, complex (60-74 min)63$164$434
Nerve conduction, 9-10 studies58$161$450
Exam of neurobehavioral status, first hour56$70$124
Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box47$99$250
Office visit, established patient (20-29 min)47$67$212
New patient office visit (45-59 min)40$124$350
Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity34$78$350
Telephone medical discussion with physician, 21-30 minutes32$90$150
Nerve conduction, 11-12 studies28$191$450
Telephone medical discussion with physician, 5-10 minutes28$43$75
Injection of chemical for paralysis of nerve muscles on side of face25$94$360
Nerve conduction, 7-8 studies25$135$300
New patient office visit (30-44 min)20$80$300
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or18$25$65
EEG, extended monitoring16$329$550
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$246,073
Total received (2018-2024)
Avg $35,153/year across 7 years
Top 2% in FL for neurology
87
Companies
1,955
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$220,291 (89.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,782 (10.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$36,487
2023
$56,828
2022
$23,171
2021
$26,031
2020
$22,699
2019
$49,355
2018
$31,502

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ACADIA Pharmaceuticals Inc
$60,318
ABBVIE INC.
$46,533
Acorda Therapeutics, Inc
$31,798
Teva Pharmaceuticals USA, Inc.
$30,087
Allergan, Inc.
$29,893
Allergan Inc.
$26,155
GENZYME CORPORATION
$2,385
Biogen, Inc.
$1,280
Novartis Pharmaceuticals Corporation
$1,080
EMD Serono, Inc.
$961
Alexion Pharmaceuticals, Inc.
$958
UCB, Inc.
$854
Amgen Inc.
$811
Genentech USA, Inc.
$733
Lilly USA, LLC
$718
ARGENX US, INC.
$661
Horizon Therapeutics plc
$646
Sunovion Pharmaceuticals Inc.
$618
Harmony Biosciences LLC
$517
JAZZ PHARMACEUTICALS INC.
$509
Amneal Pharmaceuticals LLC
$456
US WorldMeds, LLC
$436
CSL Behring
$429
PFIZER INC.
$338
Celgene Corporation
$337
Alnylam Pharmaceuticals Inc.
$314
Neurocrine Biosciences, Inc.
$303
Eisai Inc.
$287
Vanda Pharmaceuticals Inc.
$262
TG THERAPEUTICS, INC.
$258
Grifols USA, LLC
$253
Jazz Pharmaceuticals Inc.
$249
AbbVie Inc.
$243
GE HEALTHCARE
$204
Kyowa Kirin, Inc.
$200
Adamas Pharmaceuticals, Inc.
$190
Mallinckrodt LLC
$183
ANI Pharmaceuticals, Inc.
$178
Otsuka America Pharmaceutical, Inc.
$170
Abbott Laboratories
$163
Supernus Pharmaceuticals, Inc.
$150
Lundbeck LLC
$150
BIOTRONIK INC.
$139
CATALYST PHARMACEUTICALS, INC.
$138
Takeda Pharmaceuticals U.S.A., Inc.
$138
Impax Laboratories, Inc.
$131
TG Therapeutics, Inc.
$129
Janssen Pharmaceuticals, Inc
$120
AstraZeneca Pharmaceuticals LP
$119
Axsome Therapeutics, Inc.
$118
Avanir Pharmaceuticals, Inc.
$101
Mallinckrodt Enterprises LLC
$97
Merz North America, Inc.
$94
Merz Pharmaceuticals, LLC
$94
Corium, LLC
$86
E.R. Squibb & Sons, L.L.C.
$84
Upsher-Smith Laboratories LLC
$82
GE Healthcare
$82
HARMONY BIOSCIENCES LLC
$78
Strongbridge US INC.
$71
Biohaven Pharmaceuticals, Inc.
$70
Avion Pharmaceuticals
$70
Biohaven Pharmaceutical Holding Company Ltd.
$68
MITSUBISHI TANABE PHARMA AMERICA, INC.
$67
MDD US Operations, LLC
$66
BANNER LIFE SCIENCES, LLC
$64
Banner Life Sciences, LLC
$52
Boston Scientific Corporation
$47
Exeltis, USA Inc.
$32
Avadel CNS Pharmaceuticals, LLC
$28
Promius Pharma LLC
$27
REVANCE THERAPEUTICS, INC.
$25
ARBOR PHARMACEUTICALS, INC.
$24
Cycle Pharmaceuticals Inc
$24
Mallinckrodt Hospital Products Inc.
$23
UPSHER-SMITH LABORATORIES LLC
$22
Inspire Medical Systems, Inc.
$22
AbbVie, Inc.
$21
Harmony Biosciences Llc
$20
MERZ NORTH AMERICA, INC.
$20
SANOFI-AVENTIS U.S. LLC
$19
Xeris Pharmaceuticals, Inc.
$19
Merck Sharp & Dohme LLC
$16
Medtronic Vascular, Inc.
$15
Mitsubishi Tanabe Pharma America, Inc.
$15
ASSERTIO THERAPEUTICS, Inc.
$14
Piramal Imaging Limited
$13
Top 3 companies account for 56.3% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Activase · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BIOMONITOR · BOTOX · BOTOX - NEUROLOGY · BOTOX COSMETIC · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · COMIRNATY · COPAXONE · CREXONT · DAXXIFY · DAYBUE · DUOPA · Dhivy · Duopa · EMGALITY · Enspryng · Evrysdi · FABRAZYME · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GENERAL - DBS · GILENYA · GOCOVRI · Gamunex-C · General - DBS · Gocovri · Gralise · HETLIOZ · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INSPIRE · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LUMRYZ · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · ONZETRA Xsail · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · Reveal LINQ · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · Soliris · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tascenso ODT · UBRELVY · ULTOMIRIS · UPLIZNA · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · Wakix · XEOMIN · XYREM · XYWAV · Xadago · Xeomin · Xyrem · ZEPOSIA · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for neurology in FL.

Equivalent to $14,673 per 100 Medicare services performed
Looking for a neurology in Orlando?
Compare neurologys in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
92
Per 100K population
6.4
County median income
$77,011
Nearest hospital
ORLANDO HEALTH
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Klafter is a clinical cardiology specialist, with above-average Medicare volume (top 23% in FL), and high industry engagement (speaking/promotional, top 2%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Klafter experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Klafter performed 377 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Klafter receive payments from pharmaceutical companies?
Yes. Dr. Klafter received a total of $246,073 from 87 companies across 1,955 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Klafter's costs compare to other neurologys in Orlando?
Dr. Klafter's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Klafter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →